[Preliminary study for the evaluation of the feasibility of a multicenter clinical trial for the evaluation of the therapeutic efficacy of an antithrombin III concentration (Immuno) in the intravascular coagulation syndrome].
Palareti
G
G
Servizio di Angiologia e Malattie della Coagulazione, Policlinico S. Orsola, Bologna.
Legnani
C
C
Ludovici
S
S
Maccaferri
M
M
D000293:Adolescent; D000328:Adult; D000368:Aged; D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use; D000990:Antithrombin III / Q000009:adverse effects / Q000627:therapeutic use*; D001803:Blood Transfusion; D003131:Combined Modality Therapy; D004211:Disseminated Intravascular Coagulation / Q000097:blood / Q000188:drug therapy* / Q000628:therapy; D005260:Female; D006470:Hemorrhage / Q000139:chemically induced; D006801:Humans; D008297:Male; D008875:Middle Aged; D015337:Multicenter Studies as Topic; D010865:Pilot Projects; D016032:Randomized Controlled Trials as Topic
D000925:Anticoagulants; D000990:Antithrombin III
Studio preliminare per la valutazione di fattibilità di uno studio clinico policentrico per la valutazione dell'efficacia terapeutica di un concentrato di antitrombina III (immuno) nella sindrome da coagulazione intravascolare.